BioDelivery Sciences reports Q2 results

• BioDelivery Sciences (NASDAQ:BDSI +2.3%) Q2 results: Revenues: $5M (+194.1%); R&D Expense: $4M (-11.1%); SG&A: $12.5M (-6.0%); Operating Loss: ($15.6M) (+16.6%); Net Loss: ($16.5M) (+14.1%); Loss Per Share: ($0.31) (+16.2%); Quick Assets: $57.5M (-31.2%); CF Ops: ($28.6M) (-47.4%).
• No guidance given.